Medicine & Life Sciences
Arsenicals
100%
oxophenarsine
92%
Clinical Trials, Phase I
82%
Drug Development
64%
Arsenic
54%
phenylarsonous acid
49%
benzenearsonic acid
48%
Glycine
45%
ATP Translocases Mitochondrial ADP
34%
Amino Acids
31%
Mitochondrial Proteins
25%
Mitochondrial Membranes
25%
Neoplasms
21%
Cysteine
21%
Membrane Proteins
18%
Antioxidants
16%
Clinical Studies
15%
Clinical Trials
14%
Neoplasm Metastasis
13%
Therapeutics
11%
Pharmaceutical Preparations
9%
Chemical Compounds
Phenylarsonous Acid
69%
Glycine
59%
Phenylarsonic Acid
55%
Pharmaceutical
49%
Antiangiogenic
46%
Parenteral
43%
Cysteine Residue
35%
Refractory
35%
Adenine
31%
pH Value
28%
Nucleotide
27%
Antioxidant Agent
25%
Chemical Transformation
21%
Oxidation Reaction
15%
Protein
13%
Application
10%